Table 1.
Primary antibody | Antibody dilution (final concentration) | Antibody incubation time | Opal™ fluorophore (dilution) |
---|---|---|---|
Anti-human CD21 [1F8] | 1:10 (199 μg/mL) | Overnight (16–18 h) | 520 (1:100) |
Anti-human CD208/DC-LAMP | 1:100 (10 μg/mL) | 1 h | 540 (1:100) |
Anti-human CD4 [EPR6855] | 1:1000 (0.143 μg/mL) | 1 h | 570 (1:100) |
Anti-human PNAd [MECA-79] | 1:100 (10 μg/mL) | Overnight (16–18 h) | 620 (1:100) |
Anti-human CD8 alpha [C8/144B] | 1:50 (10 μg/mL) | 1 h | 650 (1:100) |
Anti-human CD19 [EPR5906] | 1:300 (6.12 μg/mL) | 1 h | 690 (1:100) |